Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitotic spindle positioning protein (MISP) is an actin-bundling and focal adhesion-associated protein that plays a critical role in proper mitotic spindle positioning within cells. It operates at the interface of the actin cytoskeleton and microtubule dynamics during cell division, localizing to actin-rich structures and retraction fibers, and interacting with spindle positioning machinery such as dynactin and EB1 in a PLK1-dependent manner. MISP is phosphorylated by CDK1 during mitosis, and its depletion leads to mitotic arrest, reduced tension at kinetochores, chromosome misalignment, and increased spindle multipolarity, especially in cancer cells with extra centrosomes. It is essential for directed cell migration, spindle orientation, and may be required for proper Golgi stacking. Mutations or loss of MISP disrupt critical cytoskeletal interactions and can result in defective cell division and tumorigenesis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitotic spindle positioning protein (MISP).